Introduction
Phosphatidylinositol-3-kinases (PI3K) are lipid kinases that phosphorylate the inositol ring 3 0 -hydroxyl group of inositol phospholipids. PI3Ks have been classified on the basis of lipid target specificity, enzyme structure and mode of regulation (Curnock et al., 2002) . The class I PI3Ks function as heterodimers, consisting of a regulatory and catalytic subunit, and are subdivided into class 1A and 1B distinguished by both enzyme structure and mode of regulation. Whereas the more widely studied class IA PI3Ks are activated by receptor tyrosine kinases, class IB PI3K is activated by G protein-coupled receptors (GPCR) (Stephens et al., 1994 (Stephens et al., , 1997 . Class IB PI3K consists of one known catalytic subunit, p110g, which interacts with the regulatory subunits p101 or the newly identified p87 PIKAP to comprise PI3Kg (Stephens et al., 1997; Suire et al., 2005; Voigt et al., 2006) . The unique mode of regulation of PI3Kg through GPCR is attributed to binding sites in the regulatory subunits for Gbg and p110g (Voigt et al., 2005) .
PI3Ks have diverse roles in cell signaling including regulation of cell survival, chemotaxis, membrane ruffling, glucose transport, superoxide production, actin reorganization and inflammation (Curnock et al., 2002) . Compared to the extensively studied class IA PI3Ks, relatively little is known about the role of PI3Kg in normal cellular function or in disease induction. PI3Kg expression is detected predominantly in leukocytes (Vanhaesebroeck et al., 1997; Okkenhaug and Vanhaesebroeck, 2003) . Studies using p110g À/À mice have shown that PI3Kg expression is not required for B-or T-cell development, but is required to regulate T-lymphocyte proliferation and cytokine production and plays a major role in the immune response (Hirsch et al., 2000; Sasaki et al., 2000) .
Both class IA and IB PI3Ks have been implicated as oncogenes. Mutations in class IA PI3K and in molecules within its signaling pathways have been associated with a wide range of malignancies (Abdel-Mageed and Agrawal, 1997; Cairns et al., 1997; Shayesteh et al., 1999; Woenckhaus et al., 2002; Campbell et al., 2004; Goel et al., 2004; Khan et al., 2004; Samuels and Velculescu, 2004; Hennessy et al., 2005; Kang et al., 2005; Bader et al., 2006) . Specifically, mutations in the class IA catalytic subunit, p110a, have been linked to many forms of malignancy, but somatic mutations in genes encoding other PI3K catalytic isoforms have not been reported in tumors (Samuels and Velculescu, 2004) . Somatic mutations in the regulatory subunits of class IA PI3K have been identified in tumors of the ovary, colon and lung as well as in a lymphoma-derived cell line (Jimenez et al., 1998; Jucker et al., 2002) . Recent reports suggest that overexpression of the PI3K catalytic subunits may also render them transforming, since overexpression of wild-type p110b, p110d or p110g was shown to transform chicken embryo fibroblasts . The constitutively active tyrosine kinase oncogene, Bcr-Abl, has been shown to stimulate p110g expression in chronic myeloid leukemia (CML) cell lines, further implicating the overexpression of normal p110g in malignancy (Hickey and Cotter, 2006) . These recent reports are the first to implicate the catalytic subunit of PI3Kg as a potential oncogene.
Our recent studies have implicated p101, the regulatory subunit of PI3Kg, as a potential oncogene. Specifically, the p101 gene was recently identified as a common site of retroviral integration in T-cell lymphomas induced in mice by MoFe2-MuLV, a unique recombinant gammaretrovirus (Johnson et al., 2005) . Identification of the p101 gene as a common integration site suggests that it encodes an oncogene capable of inducing T-cell lymphoma, and with malignant potential activated by insertion of adjacent retroviral transcriptional regulatory signals (Johnson et al., 2005) . The current studies explore the possible effects of p101 expression and PI3Kg signaling on T-cell malignancy by examining the influence of p101 on T-cell growth and survival. The findings provide the first evidence that p101 overexpression alone can activate the PI3K pathway, specifically, by activating p110g and sensitizing it to activating signals. While high levels of p101 overexpression induced apoptosis, moderate p101 overexpression in T-cell lines conferred a survival advantage, apparently mediated by Akt phosphorylation.
Results

Transient p101 overexpression reduces the viability of T-cell lines
To examine the impact of altered p101 expression on growth and survival in T-cell lines, the full-length p101 cDNA was expressed as an N-terminal YFP fusion protein (YFPp101) in human T-cell lines Molt-4 and Jurkat. As a control, parallel studies were conducted with the YFP protein alone. Expression of YFPp101 was confirmed by flow cytometric analysis of YFP fluorescence and by immunoblot analysis using an YFPspecific antibody (Figure 1a Together, the analyses of sub-G 1 DNA content and cleaved caspase-3 indicate that the loss of YFP fluorescence and decreased viability of YFPp101-expressing cells is due to apoptosis.
p101 overexpression in T-cell lines activates Akt through activation of PI3Kg
The finding that YFPp101 overexpression induces apoptosis was unexpected, since PI3Ks are known to be major activators of the pro-survival Akt pathway (Vanhaesebroeck and Alessi, 2000) . Thus, Akt activation was analysed in YFP-and YFPp101-expressing cells by immunoblot using a phospho-Akt (p-Akt)-specific antibody. The Jurkat T-cell line is known to be deficient in expression of the lipid phosphatases SHIP and PTEN. As a consequence, Jurkat cells contain a high constitutive level of phosphorylated Akt that is resistant to the broad PI3K inhibitor LY294002 (Freeburn et al., 2002) . For this reason, analyses of Akt activation in response to p101 overexpression in the present study were performed using Molt-4 cells. At 40 h posttransfection, YFPp101 expression in Molt-4 cells resulted in a 1.5-fold increase in p-Akt levels as compared to YFP-expressing cells, after normalizing for the loading control (Figure 4a ). To test the prediction that Akt activation is PI3Kg specific, we used the PI3K inhibitor, caffeine. Caffeine is useful for . It is known that PI3Kg activation depends on p101-mediated recruitment of the enzyme to the plasma membrane site of GPCR signaling. PI3Kg activation is therefore sensitive to formyl-met-leu-phe (fMLP)-stimulation because fMLP acts through a GPCR (Brock et al., 2003) . Treatment with caffeine in the presence of fMLP demonstrated a more robust activation of Akt in YFPp101-expressing cells, presumably through PI3Kg activation (Figure 4b , lanes 3 and 4). In contrast, Akt activation was not observed in the presence of the broad PI3K inhibitor LY294002, even in the presence of fMLP (Figure 4b , lanes 5-8). These results indicate that Akt activation in p101-overexpressing cells is a consequence of increased PI3Kg activity. Since Akt activation in YFPp101-expressing cells occurred as a consequence of p101 overexpression alone, we predicted that p110g levels were constant in both YFP-and YFPp101-expressing cells. To test this hypothesis, the levels of p110g expression in YFP-and YFPp101-expressing Molt-4 cells were examined by intracellular flow cytometry. The results demonstrated that p110g expression is not affected by p101 overexpression (Figure 4c ), thus indicating that p101 overexpression directly activates p110g and sensitizes it to stimulatory signals such as fMLP. Similarly, Akt expression was not altered by p101 overexpression (Figure 4c ).
Stable overexpression of p101 protects T-cell lines from apoptotic induction
Having shown that YFPp101 expression both induces apoptosis and activates the Akt pathway in transiently transfected cells, it was of interest to determine whether stable overexpression of p101 could be established. YFP-and YFPp101-expressing Molt-4 cells were seeded in selective medium 72 h post-transfection and cultured for 21 days, after which expression of the transfected gene was monitored by flow cytometry and immunoblot analysis ( Figure 5 ). Analysis of the resulting transfectant lines indicated that stable expression of both YFP and YFPp101 was established (Figure 5a ), albeit at only moderate levels of YFPp101 expression (mean fluorescent intensity ¼ 11.7 for YFPp101 vs 25 for YFP; Figure 5b ). The possible influence of p101-mediated Akt activation on cell survival was examined by ultraviolet (UV)-irradiating stable YFP-and YFPp101-expressing cells to induce apoptosis. Apoptosis was measured at regular intervals after irradiation by quantifying cleaved caspase-3 expression ( Figure 6 ). By 3 h after UVirradiation, the number of YFP-expressing cells containing cleaved caspase-3 had increased more than threefold, but no increase in YFPp101-expressing cells was observed. By 10 h after UV-irradiation, more YFPexpressing cells contained cleaved caspase-3 (67%) than YFPp101-expressing cells (38%). The protection from 
Discussion
Identification of the p101 gene as a target for common integration in a retroviral tagging study suggested that p101 overexpression may play a role in the induction of T-cell malignancy (Johnson et al., 2005) . It is noteworthy that p101 had not previously been identified as a common integration site in any other model of retrovirus-induced lymphoma. It is known that p101 binds to p110g, the catalytic subunit of PI3Kg and assists in activation by recruiting the heterodimer complex to the membrane following GPCR activation (Brock et al., 2003) . Relatively little is known, however, about how p101 regulates PI3K signaling or how cell function is thereby affected. In the present study, an N-terminal fusion protein of p101, YFPp101, was overexpressed in T-cell lines as a first step in understanding its possible role in regulating T-cell growth and survival (Figure 1) . Others have amply demonstrated that the N-terminal tagging of p101 with YFP does not alter its ability to bind and activate p110g (Brock et al., 2003) . The present results indicate that in T-cell lines, p101 overexpression activates p110g and further sensitizes it to GPCR activation. In addition, p101 contributes to cell survival, most likely by activating the Akt pro-survival pathway dependent on the level of expression. The initial observation suggesting a role for p101 in cell survival was the loss of YFP fluorescence in cells transiently expressing YFPp101, particularly those cells with high mean fluorescence intensity (Figure 2 ). This observation suggested that p101 might be toxic when expressed at the highest levels. Indeed, apoptotic cell death was documented within 40 h of transfection, as measured by sub-G 1 DNA content and cleaved caspase-3 (Figure 3 ). While we cannot exclude the possibility that some of the loss in YFP fluorescence was due to unstable YFPp101 expression, our studies show that overexpressed p101 was still capable of inducing apoptosis and activating Akt at 40 h post-transfection (Figures 3 and 4) . Although p101 has been reported to be unstable when overexpressed in HEK and COS-7 cells in the absence of p110g (Brock et al., 2003; Voigt et al., 2006) , our studies suggest that p101 stability may be cell type-specific.
We did not expect to find that YFPp101 induced apoptosis, since it activated the pro-survival protein, Akt (Figure 4 was mediated specifically through p110g, Akt activation was monitored in cells treated with caffeine, a PI3K inhibitor to which p110g is least sensitive. The results demonstrated higher levels of p-Akt in YFPp101-expressing cells than in controls, as well as a robust response to fMLP even in the presence of caffeine, thus implicating p110g (Figure 4b) . Along with the finding that p110g expression was not affected by p101 overexpression (Figure 4c ), these results suggest that p101 overexpression in T-cell lines activates p110g and sensitizes it to further activation through GPCR stimulation. While unexpected, other evidence is consistent with our finding that increased PI3Kg activity may be associated with cell death. HEK cells transfected with genes encoding the entire PI3Kg system (YFPp110g, p101 and Gbg) demonstrated a rounded morphology and detached from the culture dishes, hallmarks of death in these cells. The phenotype was specific to PI3Kg activity, since cell rounding was inhibited in the presence of the PI3K inhibitor, wortmannin or in the presence of a kinase-deficient p110g mutant (Brock et al., 2003) . Despite induction of apoptosis following p101 overexpression, a population of surviving cells persists and can be expanded in culture. These cells stably express YFPp101, although with a lower mean YFP fluorescence intensity than YFP-expressing cells (11.7 vs 25; Figure 5b ). This observation supports the abovementioned interpretation that p101 toxicity is associated with high levels of expression. The pro-survival effect of Akt activation was apparent in cells that stably express moderate YFPp101 levels, since such cells were significantly protected from UV irradiation-induced cell death ( Figure 6 ). The survival advantage conferred by p101 overexpression suggests a mechanism by which p101 might act in the malignant process. Other reports have indicated a potentially oncogenic role for PI3Kg, but these have focused on deregulated expression of the p110g catalytic subunit. In one recent study, p110g was found to transform chicken embryo fibroblasts when overexpressed in its wild-type form . In CML cell lines, the Bcr-Abl fusion oncoprotein has been shown to increase expression of p110g, a phenotype associated with increased proliferation and resistance to apoptosis in CML (Hickey and Cotter, 2006) . Taken together, our findings indicate that p101 has the potential to induce apoptosis or to confer a survival advantage, depending on the level of expression. This phenotype is reminiscent of oncogenes such as c-myc that have clear malignant potential, but may induce apoptosis under certain conditions (Grandori et al., 2000) .
In summary, the results reported here are the first to suggest that altered expression of p101, the regulatory subunit of PI3Kg, plays a role in T-cell malignancy. The likely mechanism by which p101 may contribute to malignancy is through activation of p110g, and consequently PI3Kg, resulting in activation of the prosurvival factor, Akt. Moreover, the role of PI3Kg in human cancer may be underestimated because no mutation in the gene is required to activate the oncogenic potential. Our findings suggest further that p101 may positively regulate p110g not only through recruitment to the plasma membrane, but also by direct activation. Finally, our results demonstrate that the stoichiometry of p110g and p101 is an important factor in regulating PI3Kg signaling, and that p101 is likely the limiting protein in the complex.
Materials and methods
Cell lines and plasmids
Human lymphoid leukemia lines Jurkat clone E6-1 (ATCC TIB-152) and Molt-4 (ATCC CRL 1582) were maintained in RPMI 1640 þ Glutamax with 10% fetal bovine serum. The plasmid pEX_EF1_YFP-PI3Kp101 (YFPp101; ATCC #10374083) encodes murine p101 fused to YFP at the N terminus. The plasmid pDS_EF1-YFP-XB (YFP; ATCC #10326351) encodes YFP. Cells were transfected by electroporation using an Electro Cell Manipulator, ECM 630. Briefly, approximately 1.2 Â 10 7 cells were transfected using 230 V (Molt-4 cells) or 250 V (Jurkat cells) in antibiotic-free medium with 20 or 30 mg of cesium chloride-purified plasmid DNA. Cell lines stably expressing YFP and YFPp101 were established by culturing recipient cells in the presence of 700 mg/ml G418 for 3 weeks. Establishment of stable cell lines was confirmed by flow cytometry for YFP fluorescence and immunoblot analysis for the YFP tag.
Flow cytometry
Cells were fixed in 1.5% formaldehyde while vortexing and incubated at 371C for 15 min. Fixed cells were permeabilized in ice-cold 90% methanol and incubated at 41C for 30 min. Permeabilized cells were washed two times in a stain buffer of phosphate-buffered saline (PBS) with 0.5% bovine serum albumin, and were used for intracellular staining. For staining, 1.5 Â 10 6 cells were incubated at room temperature with primary antibody for 1 h and secondary antibody for 30 min. Samples were then washed with PBS. Flow cytometry was performed using a Coulter Epics XL with analysis using CellQuest Pro Software (BD Beckton Dickinson, Franklin Lakes, NJ, USA). Dead cells were excluded from analysis based on forward and side scatter pattern. Transfected cells were identified by YFP fluorescence. Primary antibodies were directed against cleaved caspase-3 (Asp175), Akt, p-Akt (Ser 473) and p110g (Cell Signaling Inc., Danvers, MA, USA). Secondary antibody was goat anti-rabbit IgG conjugated to Alexa Fluor 647 (Molecular Probes, Invitrogen Corporation, Carlsbad, CA, USA). Cell cycle analysis was performed by incubating fixed and permeabilized cells with 1 ml of propidium iodide/RNase staining buffer (BD Pharmingen, San Jose, CA, USA) for 15 min at room temperature. 
Apoptosis assay
Immunoblot
Whole cell lysates were prepared by resuspending cells in 1 Â radioimmuno precipitation assay buffer containing a protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN, USA), 1 mM Na 3 VO 4 and 1 mM NaF (Sigma) followed by incubating on ice for 30 min with periodic vortexing. Lysates were cleared by centrifugation for 15 min at 13 000 r.p.m. (41C). The protein concentration in whole cell lysates was determined by the Bradford method (BioRad, Hercules, CA, USA). For some studies, cells were serum-starved for 20 h, treated with 30 mM LY, 1 mM Wortmannin or 10 mM fMLP for 30 min or 0.5 mM caffeine for 2 h. Co-immunoprecipitation reactions were performed in EBC buffer (50 mM Tris, pH 8.0, 120 mM NaCl, 0.5% NP40 and 5 mM dithiothreitol (DTT)) overnight at 41C with an antibody specific for p110g (Cell Signaling Inc.). The reaction was washed, precipitated with protein G beads for 2 h at 41C, washed and resuspended in Laemmli buffer for analysis. Each sample (50 mg) was denatured and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis on a Novex 4-16% gradient gel (Invitrogen Corporation) and transferred to a nitrocellulose membrane (IBC BioExpress, Kayville, UT, USA). Membranes were blocked from nonspecific binding with 5% nonfat dried milk and PBS containing 0.1% Tween-20 (PBST) for 1 h at room temperature. Membranes were incubated at 41C overnight in PBST. Antibodies against Akt and p-Akt (Ser473) (Cell Signaling Inc.) were used at a 1:1000 dilution followed by horseradish peroxidase-conjugated secondary antibodies. Immune complexes were detected using Supersignal West Femto Maximum Sensitivity Substrate ECL system (Pierce Biochemicals, Rockford, IL, USA). p-Akt signals in Figure 4a were quantified by measuring densitometric volume normalized to Akt using ImageQuant software (Molecular Dynamics Inc., Piscataway, NJ, USA). 
Cell viability
